Literature DB >> 8709224

Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.

D Y Wu1, G V Kalpana, S P Goff, W H Schubach.   

Abstract

Epstein-Barr nuclear antigen 2 (EBNA2), one of the six viral nuclear proteins expressed in latently infected B lymphocytes, is essential to the immortalization of B cells by Epstein-Barr virus (EBV). EBNA2 promotes transcriptional transactivation of viral and cellular genes by acting as an adapter molecule that binds to cellular sequence-specific DNA-binding proteins, JK recombination signal-binding protein (RBP-JK), and PU.1 and engages multiple members of the RNA polymerase II transcription complex. In the present study, we show that EBNA2 also interacts with hSNF5/Ini1, the human homolog of the yeast transcription factor SNF5. Gel filtration fractionation of partially purified EBV-positive lymphocyte nuclear extracts shows that a fraction of EBNA2 coelutes with both hSNF5/Ini1 and BRG1, a human homolog of SWI/SNF2, in the high-molecular-mass region (1.5 to 2.0 MDa) of a Superose 6 chromatogram. An affinity-purified rabbit antibody directed against hSNF5/Ini1 coimmunoprecipitates EBNA2 from this high-molecular-mass nuclear protein fraction, demonstrating that EBNA2 and hSNF5/Ini1 interact in vivo. This interaction is restricted to a subpopulation of phosphorylated viral EBNA2. Deletion mutation analysis of EBNA2 shows that the proline-rich aminoterminal end and a domain within the divergent region of EBNA2 mediate EBNA2-hSNF5/Ini1 interaction. Since the SNF-SWI complex participates in gene regulation through the alteration of nucleosome configuration and may be a component of the RNA polymerase II holoenzyme, the EBNA2-hSNF5/Ini1 interaction supports the hypothesis that EBNA2 facilitates transcriptional transactivation by acting as a transcription adapter molecule. We postulate that EBNA2 engages the hSNF-SWI complex to generate an open chromatin conformation at the EBNA2-responsive target genes, thereby potentiating the function of the RBP-JK-EBNA2-polymerase II transcription complex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709224      PMCID: PMC190622          DOI: 10.1128/JVI.70.9.6020-6028.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling.

Authors:  C J Wilson; D M Chao; A N Imbalzano; G R Schnitzler; R E Kingston; R A Young
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

2.  DNA-binding properties of the yeast SWI/SNF complex.

Authors:  J Quinn; A M Fyrberg; R W Ganster; M C Schmidt; C L Peterson
Journal:  Nature       Date:  1996-02-29       Impact factor: 49.962

3.  The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE.

Authors:  X Tong; R Drapkin; R Yalamanchili; G Mosialos; E Kieff
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

4.  Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5.

Authors:  G V Kalpana; S Marmon; W Wang; G R Crabtree; S P Goff
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

5.  The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2.

Authors:  X Tong; R Drapkin; D Reinberg; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

6.  Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

Authors:  J J Hsieh; S D Hayward
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm.

Authors:  C Muchardt; C Sardet; B Bourachot; C Onufryk; M Yaniv
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

Review 9.  The SWI-SNF complex: a chromatin remodeling machine?

Authors:  C L Peterson; J W Tamkun
Journal:  Trends Biochem Sci       Date:  1995-04       Impact factor: 13.807

10.  The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.

Authors:  L Waltzer; F Logeat; C Brou; A Israel; A Sergeant; E Manet
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more
  64 in total

1.  A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

Authors:  S Zhou; M Fujimuro; J J Hsieh; L Chen; S D Hayward
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.

Authors:  Michiko Tanaka; Akihiko Yokoyama; Mie Igarashi; Go Matsuda; Kentaro Kato; Mikiko Kanamori; Kanji Hirai; Yasushi Kawaguchi; Yuji Yamanashi
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.

Authors:  Martin Dufva; Josefine Flodin; Annika Nerstedt; Ulla Rüetschi; Lars Rymo
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

4.  Wongabel rhabdovirus accessory protein U3 targets the SWI/SNF chromatin remodeling complex.

Authors:  D Albert Joubert; Julio Rodriguez-Andres; Paul Monaghan; Michelle Cummins; William J McKinstry; Prasad N Paradkar; Gregory W Moseley; Peter J Walker
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

5.  Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice.

Authors:  C W Roberts; S A Galusha; M E McMenamin; C D Fletcher; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

6.  EBNA3C coactivation with EBNA2 requires a SUMO homology domain.

Authors:  Adam Rosendorff; Diego Illanes; Gregory David; Jeffrey Lin; Elliott Kieff; Eric Johannsen
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.

Authors:  Nathalie Alazard; Henri Gruffat; Edwige Hiriart; Alain Sergeant; Evelyne Manet
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation.

Authors:  Bogaslaw Kwiatkowski; Szu Yu Jenny Chen; William H Schubach
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.

Authors:  Alexey V Gordadze; Chisaroka W Onunwor; RongSheng Peng; David Poston; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.

Authors:  Rongsheng Peng; Stephanie C Moses; Jie Tan; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.